Press release
Special student rate for RNA Nanotechnology conference
Fusion Conferences and the Chairs of RNA Nanotechnology have introduced a Special Student Rate for their conference on 01-04 August 2016.The conference, to be held at Wokefield Park in Berkshire, UK, sold out earlier this month with registrations being closed off to the public, but Fusion have opened up some spaces to allow students to enjoy the conference at a discounted rate.
Dr. Peixuan Guo of Ohio State University and one of the conference’s chairs, says, “It is really important to us that the discussions and unpublished work being showcased in this conference are shared with the bright minds of the future. We want to be able to support students by providing access for them to attend and engage in such a vital topic.”
After chemical drugs and protein-based drugs, it is believed RNA drugs will be the next milestone in pharmaceutics. The field of RNA Nanotechnology was first realised and demonstrated in 1998 by Dr. Peixuan Guo, and since then it has grown into a mature field composed of several subfields covered by many disciplines such as chemistry, biochemistry, molecular biology, microbiology and many more. Dr. Guo says “There is a need for an all-encompassing conference of RNA nanotechnology that brings together all scientists in the field”.
Key sessions to be discussed include Biophysical approaches in RNA Nanotechnology, RNA Nanoparticle structure and folding, RNA Modeling and Nanoimmunology, amongst others.
The cost for a student to attend will be £300 and this will cover registration for all four days of the conference, daily refreshments, lunch and dinner on 01, 02 and 03 August. Accommodation (if required) and transportation to and from the conference venue will need to be arranged independently.
The deadline for students to register is Wednesday 27 July.
More information can be found at https://www.fusion-conferences.com/conference47.php.
To register please contact laura@fusion-conferences.com.
Fusion Conferences specialise in organising scientific based conferences within the academic and corporate industry for those working at the frontiers of physical, medical, life sciences and their related technologies.
Fusion Conferences Ltd, Unit 5D, Lynx Business Park, Fordham Rd, Snailwell, Cambridgeshire, CB8 7NY
Contact: Stephanie Scott
steph@fusion-conferences.com
01638 724137
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Special student rate for RNA Nanotechnology conference here
News-ID: 351042 • Views: …
More Releases from Fusion Conferences
FusionAnalyticsWorld.com Launches New Website, Offering a platform for learning …
FusionAnalyticsWorld.com is recently launching its website which is poised to become “The Analytics Encyclopedia”. The site aims to assist analytics professionals and enthusiasts a platform for learning as well as sharing content on Data Science, Big Data, Data Mining, and Business Analytics.
The process is quite simple. Readers should visit the new site and register with us by opening an account. Once you are done, from your account page you…
Fusion Analytics World Launches New Website, Offering a platform for learning an …
Fusion Analytics World is recently launching its website which is poised to become “The Analytics Encyclopedia”. The site aims to assist analytics professionals and enthusiasts a platform for learning as well as sharing content on Data Science, Big Data, Data Mining, and Business Analytics.
The process is quite simple. Readers should visit the new site and register with us by opening an account. Once you are done, from your account…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
